Atom Investors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Atom Investors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-9,611	Closed	-$451K	–	511
2020 Q1	$451K	Buy	9,611 +1,982	+26%	+$127K	0.04%	215
2019 Q4	$556K	Sell	7,629 -179	-2%	-$10.9K	0.05%	177
2019 Q3	$407K	Buy	7,808 +1,921	+33%	+$102K	0.03%	232
2019 Q2	$295K	Sell	5,887 -111,421	-95%	-$5.42M	0.02%	344
2019 Q1	$6.1M	Buy	+117,308	New	+$5.4M	0.52%	62

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Atom Investors's MYOK Position: Q2 2020 in Review

Atom Investors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q2 2020, closing a stake of 9,611 shares — an estimated $451K sold.

Atom Investors first reported a position in MYOK in Q1 2019 and held it in 5 quarters. The position peaked at $6.1M in Q1 2019. 235 funds tracked by Wall St. Rank hold MYOK as of Q2 2020.

Atom Investors reported no remaining MyoKardia, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Atom Investors sold 9,611 MyoKardia, Inc. Common Stock shares in Q2 2020, an estimated $451K.
Atom Investors first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 5 quarters.
Atom Investors's MyoKardia, Inc. Common Stock position peaked at $6.1M in Q1 2019.
235 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q2 2020.

Based on Atom Investors's 13F filing for Q2 2020, filed 14 Aug 2020.